Hepato-Pancreatico-Biliary (HPB) Surgeries Surgical Devices Market Report 2025

This report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.

The hepato-pancreatico-biliary (HPB) surgeries surgical devices market size has grown strongly in recent years. It will grow from $5.25 billion in 2024 to $5.66 billion in 2025 at a compound annual growth rate (CAGR) of 7.9%. The growth in the historic period can be attributed to aging population, global expansion of healthcare infrastructure, rise in minimally invasive surgeries, regulatory approvals and standardization, rising demand for ambulatory surgical centers.

The hepato-pancreatico-biliary (HPB) surgeries surgical devices market size is expected to see strong growth in the next few years. It will grow to $7.26 billion in 2029 at a compound annual growth rate (CAGR) of 6.4%. The growth in the forecast period can be attributed to increasing number of diseases associated with liver and pancreas, growing trends of gallbladder concerns in younger adults, rising medical tourism, rising attention to a healthy diet, increasing prevalence of HPB disorders. Major trends in the forecast period include remote surgical platforms, nanotechnology in surgical devices, patient-specific implants, smart surgical instruments, augmented reality (AR) in surgical planning.

The growing adoption of telehealth services is expected to drive the expansion of the healthcare virtual assistant market in the coming years. Telehealth services involve delivering health-related care, advice, education, intervention, monitoring, and remote admissions through digital communication technologies. Healthcare virtual assistants enhance these services by providing automated, round-the-clock support for patients through digital platforms. They assist with appointment scheduling, symptom checking, medication reminders, and personalized health guidance, improving accessibility and efficiency in healthcare delivery. For example, the Health Information National Trends Survey (HINTS), a US-based government agency, reported that nearly 40% of US adults utilized telehealth services in 2022, although significant barriers to access remain. As telehealth services continue to grow, the demand for healthcare virtual assistants is expected to rise.

Leading companies in the hepato-pancreatic-biliary (HPB) surgical device market are focusing on developing innovative technologies, such as robotic-assisted surgical staplers, to enhance their competitive position. The robotic-assisted surgical stapler is used in various surgical procedures, particularly by gastrointestinal surgeons, surgical oncologists, bariatric surgeons, and HPB specialists. For example, in September 2022, Olympus Corporation, a Japan-based manufacturer of optics and reprography products, launched its latest surgical visualization platform, the VISERA ELITE III. This system offers ultra-high-definition 4K resolution and fluorescence imaging, supporting multiple imaging functions to ensure precise dissection of liver and pancreatic tissues during laparoscopic procedures such as cholecystectomy and liver resections. This technological advancement enhances visualization, contributing to safer and more effective HPB surgeries.

In June 2022, Boston Scientific Corporation, a US-based manufacturing company, announced a definitive agreement to acquire a majority stake (approximately 64%) in M.I.Tech Co., Ltd, a publicly traded medical device manufacturer based in South Korea. M.I.Tech is renowned for its HANAROSTENT technology, a range of conformable, non-vascular, self-expanding metal stents that have been distributed by Boston Scientific. Valued at around $230 million, the acquisition aims to expand Boston Scientific’s portfolio in non-vascular gastrointestinal and airway stents. These stents are used to clear occlusions in areas such as the biliary tree and pancreatic duct, thereby supporting minimally invasive procedures that aid in faster patient recovery.

Major companies operating in the hepato-pancreatico-biliary (HPB) surgeries surgical devices market report are Cardinal Health Inc., Johnson & Johnson Services Ltd., General Electric Company, 3M Company, Medtronic Plc, KARL STORZ SE & Co. KG, FUJIFILM Holdings Corporation, BD CooperSurgical Inc., Koninklijke Philips N.V., Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Terumo Corporation, Smith & Nephew plc, Steris Plc, W.L. Gore & Associates Inc., Cook Medical Inc., CONMED Corporation, Richard Wolf GmbH, CooperSurgical Inc., Medi-Globe GmbH, Thompson Surgical Instruments Inc., Lotus Surgicals Pvt. Ltd., Comepa Industries, Hobbs Medical Inc., TeleMed Systems Inc., Medorah Meditek Pvt. Ltd., Origio India Pvt. Ltd.

North America was the largest region in the hepatic-pancreatic-biliary (HPB) surgical device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hepato-pancreatico-biliary (hpb) surgeries surgical devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the hepato-pancreatico-biliary (hpb) surgeries surgical devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The hepato-pancreatico-biliary (HPB) surgeries surgical devices market includes revenues earned by entities by liver surgeries, ultrasonic aspirators, liver retractors, and liver transplantation treatments. The market value includes the value of related goods sold by the service provider or included within the service offering. The hepato-pancreatico-biliary (HPB) surgeries surgical devices market also includes sales of visualization and access instruments, trocars, energy devices, and ultrasonic scalpels. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Hepato-Pancreatico-Biliary (HPB) surgeries surgical devices are specialized instruments designed for cutting, dissecting, grasping, and suturing tissues in surgical procedures involving the liver (hepato-), pancreas (pancreatic-), and bile ducts (biliary). These devices play a crucial role in performing intricate procedures on these delicate organs.

The main products in the field of hepato-pancreatic-biliary (HPB) surgeries surgical devices include electrosurgery instruments, endoscopes, hand instruments, access instruments, stents, energy/vessel sealing devices, visualization and robotic surgical systems, surgical suture and stapler devices, and fluid management systems. Electrosurgery instruments utilize high-frequency, alternating electric current to generate heat in tissues, enabling various surgical procedures such as cutting, coagulating, desiccating, or fulgurating tissue. These devices find indications in the treatment of conditions such as liver cancer, pancreatic cancer, gallstones, bile duct cancer, cirrhosis, pancreatitis, and cholecystitis. They are commonly used in hospitals, specialty clinics, trauma centers, and ambulatory surgical centers.

The hepato-pancreatic-biliary (HPB) surgeries surgical devices market research report is one of a series of new reports that provides hepato-pancreatic-biliary (HPB) surgeries surgical devices market statistics, including hepato-pancreatic-biliary (HPB) surgeries surgical devices industry global market size, regional shares, competitors with hepato-pancreatic-biliary (HPB) surgeries surgical devices market share, detailed hepato-pancreatic-biliary (HPB) surgeries surgical devices market segments, market trends, and opportunities, and any further data you may need to thrive in the hepato-pancreatic-biliary (HPB) surgeries surgical devices industry. This hepato-pancreatic-biliary (HPB) surgery surgical devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.